HLAG Antikörper (APC)
Kurzübersicht für HLAG Antikörper (APC) (ABIN3200977)
Target
Alle HLAG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Spezifität
- Reacts with the native form of human HLA-G1 on the cell surface
-
Kreuzreaktivität
- Maus
-
Kreuzreaktivität (Details)
- Also reacts with the soluble HLA-G5 isoform in its beta2-microglobulin associated form. Does not cross-react with mouse protein.
-
Aufreinigung
- Purified (liquid chromatography)
-
Immunogen
- Recombinant human HLA-G refolded with beta2-microglobulin and peptide.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
- FC: 1:100 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS, BSA 0.2 % (w/v), Sodium azide 15 mM
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store in the dark at 2-8°C. Do not freeze. Avoid prolonged exposure to light.
-
-
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
-
Andere Bezeichnung
- HLA-G
-
Gen-ID
- 3135
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-